Objective
Medical imaging technology has been improving at a rapid pace over the past decades with Ultrasound, CT, PET and MRI scanners increasing in performance. This is driven by the need to deliver faster, high quality, efficient and cost-effective healthcare. These machines generate 3D volumetric imagery as a series of 2D slices scanned through the body using radiation (ionising & non-ionising) or ultrasound. These data are presented directly to viewer(s) as full 3D images via the holographic volumetric display. The display essentially performs the inverse operation and converts the radiation into a photonic representation, showing the 2D slices as a series of “light sheets” suspended in free space.
Holoxica has pioneered a series of motion holographic video displays over the past few years. The award-winning technology produces excellent results with large, bright images floating in mid-air without the need for cumbersome glasses. The display system comprises state of the art optical components (patented Holographic Optical Element, lasers, high speed projection), embedded electronics and image processing with software. The basic principles have been proven (TRL4/5) in a series of national projects and successful completion of the project will result in a TRL7 prototype validated within realistic medical scenarios.
The benefits of the holographic volumetric display include quicker interpretation of 3D scan images, faster surgery and better quality surgical procedures. The breakthrough innovation will meet an urgent demand from medical professionals for a 3D visualisation solution that can match the performance of scanning devices. Applications include teaching/training, diagnostics/planning and live surgery.
Medical Imaging 3D Displays is a global $4.3B market by 2020, growing at 42.2% CAGR. This disruptive innovation may be used across many other multi-billion euro industries including airport security, computer monitors and consumer TV or video gaming.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciences clinical medicine surgery surgical procedures
- engineering and technology materials engineering
- medical and health sciences clinical medicine obstetrics
- engineering and technology medical engineering diagnostic imaging magnetic resonance imaging
- natural sciences physical sciences acoustics ultrasound
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-2 - SME instrument phase 2
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-SMEInst-2014-2015
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
EH9 3FF EDINBURGH
United Kingdom
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.